| 000 | 00595ngm a2200121 454500 | ||
|---|---|---|---|
| 008 | 181016s2014 xx 000 0 und d | ||
| 082 | _a615.1 | ||
| 100 | _aSINGH Kiran | ||
| 245 | _aFormulation and in-vitro evaluation of nanoparticulate drug delivery system containing antidiabetic drug | ||
| 260 | _c2014 | ||
| 500 | _aantidiabetic ; budesonide ; ciprofloxacin ; colon ; containing ; delivery ; drug ; evaluation ; for ; Formulation ; HCI ; in-vitro ; nanoparticles ; nanoparticulate ; nanosuspension ; PH-sensitive ; polymeric ; system ; systems ; targeted | ||
| 650 | _aPharmaceutics (615.1) | ||
| 999 |
_c348429 _d348429 |
||